Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 us case -control studies: II. Invasive epithelial ovarian cancers in white women

American Journal of Epidemiology

Volumn 136, Issue 10, 1992, Pages 1184-1203

  Whittmore, Alice S ^a   Harris, Robin ^a   Itnyre, Jacqueline ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogens; Fertility agents, female; Infertility; Lactation; Pregnancy

Indexed keywords

ESTROGEN; FERTILITY PROMOTING AGENT; ORAL CONTRACEPTIVE AGENT;

ARTICLE; BREAST FEEDING; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; ESTROGEN THERAPY; FEMALE; FEMALE INFERTILITY; HUMAN; HYSTERECTOMY; MENARCHE; MENOPAUSE; NULLIPARA; ORAL CONTRACEPTION; OVARY CANCER; PREGNANCY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UNITED STATES; UTERINE TUBE LIGATION;

ADULT; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; HUMAN; MIDDLE AGE; NEOPLASM INVASIVENESS; ODDS RATIO; OVARIAN NEOPLASMS; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES; WHITES;

EID: 0027092659     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a116427     Document Type: Article

References (39)

1. Byers T, Marshall J, Graham S, et al. A case-control study of dietary and nondietary factors in ovarian cancer. J Natl Cancer Inst 1983;71:681-6.
2. Hildreth NG, Kelsey JL, LiVolsi VA, et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981; 114:398-405.
3. McGowan L, Parent L, Lednar W, et al. The woman at risk for developing ovarian cancer. Gynecol Oncol 1979;7:325-44.
4. Wu ML, Whittemore AS, Paffenbarger RS Jr, et al. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive usage. Am J Epidemiol 1988;128:1216-27.
5. Rosenberg L, Shapiro S, Slone D, et al. Epithelial ovarian cancer and combination oral contraceptives. JAMA 1982 247:3210-12.
6. Hartge P, Schiffman MH, Hoover R, et al. A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989;161:10-16.
7. Casagrande JT, Louie EW, Pike MC, et al. “Incessant ovulation” and ovarian cancer. Lancet 1979; 2:170-3.
8. Cramer DW, Hutchison GB, Welch GR, et al. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst 1983;71:711-16.
9. Nasca PC, Greenwald P, Chorost S, et al. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol 1984; 119:705-13.
10. Weiss NS, Lyon JL, LifT JM, et al. Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer 1981;28:669-71.
11. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. The reduction in risk of ovarian cancer associated with oral contraceptive use. N Engl J Med 1987; 316:650-5.
12. Whittemore AS, Wu ML, Paffenbarger RS Jr, et al. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. Am J Epidemiol 1988;128:1228-40.
13. Harris R, Whittemore AS, Itnyre J, et al. Characteristics relating to ovarian cancer risk. Collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Am J Epidemiol 1992; 136: 1204-11.
14. Whittemore AS, Harris R, Itnyre J, et al. Characteristics relating to ovarian cancer risk. Collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Am J Epidemiol 1992;136:1212-20.
15. Hom-Ross PL, Whittemore AS, Harris R, et al. Characteristics relating to ovarian cancer risk. Collaborative analysis of twelve US case-control studies. VI. Nonepithelial cancers. Epidemiology 1992; 3:490-5.
16. Whittemore AS, Harris R, Itnyre J, et al. Characteristics relating to ovarian cancer risk. Collaborative analysis of 12 US case-control studies. I. Methods. Am J Epidemiol 1992; 136:1175-83.
17. Seidman DS, Slater PE, Ever-Hadani P, et al. Accuracy of mothers’ recall of birthweight and gestational age. Br J Obstet Gynaecol 1987;94:731-5.
18. Axelsson G, Rylander R. Validation of questionnaire reported miscarriage, malformation and birth weight. Int J Epidemiol 1984;13:94-8.
19. Irwin KL, Wingo PA, Lee NC. Agreement of selfreported ovarian number following gynecologic surgery with medical record reports. J Clin Epidemiol 1990;43:181-7.
20. Atlas M, Menczer J. Massive hyperstimulation and borderline carcinoma of the ovary. A possible association. Acta Obstet Gynecol Scand 1982;61: 261-3.
21. Bamford PN, Steele SJ. Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. BrJ Obstet Gynaecol 1982;89:962-4.
22. Carter ME, Joyce DN. Ovarian carcinoma in a patient hyperstimulated by gonadotropin therapy for in vitro fertilization: a case report J In Vitro Fert Embryo Transf 1987;4:126-8.
23. Ismail SM, Walker SM. Bilateral virilizing sclerosing stromal tumours of the ovary in a pregnant woman with Gorlin’s syndrome: implications for pathogenesis of ovarian stromal neoplasms. Histo-pathology 1990;17:159-63.
24. Yeh J, Ravnikar VA. Induction of ovulation with human LH-FSH and human FSH. In: Barbiéri RL, Schiff I, eds. Reproductive endocrine therapeutics. New York, NY: Alan R. Liss, Inc., 1988 5-9.
25. Davis OK, Ravnikar VA. Induction of ovulation with clomiphene citrate. In: Barbiéri RL, Schiff I, eds. Reproductive endocrine therapeutics. New York, NY: Alan R. Liss, Inc., 1988; 1-24.
26. Negri E, Franceschi S, Tzonou A, et al. Pooled analysis of 3 European case-control studies. I. Reproductive factors and risk of epithelial ovarian cancer. Int J Cancer 1991;49:50-6.
27. Franceschi S, Parazzini F, Negri E, et al. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer. III. Oral contraceptive use. Int J Cancer 1991;49:61-5.
28. Piper JM, Kennedy DL. Oral contraceptives in the United States. Trends in content and potency. Int J Epidemiol 1987;16:215-21.
29. Franceschi S, La Vecchia C, Booth M, et al. Pooled analysis of 3 European case-control studies of ovarian cancer. II. Age at menarche and at menopause. Int J Cancer 1991;49:57-60.
30. Shu XO, Brinton LA, Gao TY, et al. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 1989;49:3670-4.
31. Kvale G, Heuch I, Nilssen S, et al. Reproductive factors and risk of ovarian cancer a prospective study. Int J Cancer 1988;42:246-51.
32. Colditz GA, Stampfer MJ, Willett WC, et al. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol 1987;126:319-25.
33. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982;116:114-22.
34. Bean JA, Leeper JD, Wallace RB, et al. Variations in reporting of menstrual histories. Am J Epidemiol 1979;109:181-5.
35. Weiss NS, Lyon JL, Krishnamurthy S, et al. Noncontraceptive estrogen use and the occurrence of ovarian cancer. J Natl Cancer Inst 1982;68:95-8.
36. Hoover R, Gray LA, Fraumeni JF Jr. Stilboestrol (diethylstilbestrol) and the risk of ovarian cancer. Lancet 1977;1:533-4.
37. Booth M, Beral V, Smith P. Risk factors for ovarian cancer a case-control study. Br J Cancer 1989;60: 592-8.
38. Weiss NS, Harlow BL. Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer. Am J Epidemiol 1986;124:856-8.
39. Koepsell TD, Weiss NS, Thompson DJ, et al. Prevalence of prior hysterectomy in the Seattle-Tacoma area. Am J Public Health 1980;70:40-7.